iTeos Therapeutics
iTeos Therapeutics

iTeos Therapeutics Information

Contact top employees from iTeos Therapeutics

Summary

iTeos Therapeutics is a public company that has been in the industry for 15 years. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. The position of the President & CEO is occupied by Michel Detheux. Its headquarters is located at Gosselies, Hainaut, BE. The number of employees ranges from 25 to 100. The iTeos Therapeutics annual revenue is estimated at < 1M. Total funding of the company - $333.1M. To connect with iTeos Therapeutics employee register on SignalHire.

Organization Website

iteostherapeutics.com

Social Links

twitterlinkedIntwitter

Phone Number

3271919934

Industries

Headquarters Location

139 Main Street, Cambridge, Massachusetts, 02142 US

Employees Size

100-200 employees

Specialties

Immunotherapy, Small molecule immunomodulators, Drug discovery

SIC Code

2834, 2836

Founded

2011

Operating Status

Independent Company

Competitors

Founded
Type
Employees
Revenue
Funding
2018Privately
Held
25 - 100 2M $109M
2019Privately
Held
25 - 100 1.7M $148M
2020Privately
Held
25 - 100 < 1M $57.4M
2009Privately
Held
25 - 100 5.6M $197.7M

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at iTeos Therapeutics shows a diverse range of experience levels:
4% have been with the company for less than 1 year25% for 1–2 years17% for 3–4 years17% for 5–7 years17% for 8–10 years21% have over 11 years of service at iTeos Therapeutics
Ex-employees positions
In Company
In New Company
Contact top employees from iTeos Therapeutics
Michel Detheux
Co-founder, President & CEO
View
Peg Foley
Senior Vice President, Clinical Development
View
Sharon Arnold
Vice President Of Clinical Operations
View
Pratheep Madasamy
Senior Director, Head of Global Product & Portfolio Strategy
View
Anthony Davis
VP, Global Head of Quality
View
Ophelia Yin
Vice President, Head of Clinical Pharmacolgy
View
Matthew Gall
Chief Financial Officer
View
Kerri Keniston
Executive Assistant
View
Prakash Bolleddula
Senior Director, Clinical Pharmacology
View
Alfred Gray
Director Business Development
View
Caroline Lawton
Executive Assistant
View
Monica Glass
Associate Director, Global Product & Portfolio Strategy
View
Jeri Kim
VP Clinical Development
View
Matt Call
Chief Operating Officer
View
Nathan Stahl
Medical Affairs- North America
View
Patrick Myers
Accounting Co-op
View
Nicole Wick
Smartsheet Administrator | Timeline Visualization (Office Timeline Pro+)
View
Michael Fox
Clinical Scientist, Associate Director
View
Natalie Ren
Director of Clinical Science
View
Scott Moren
VP, Medical Affairs
View
Nicholas Corsaro
Associate Director, Contracts Attorney
View
Josh Gagnon
Lead, Clinical Business Operations
View
David Feltquate
Chief Medical Officer
View
Prakash Patel
Director, Global Regulatory Lead (Strategy, Operations, and Regulatory Intelligence)
View
Daniel Powers
Clinical Development Inupadenant Lead
View
Arpit Chokshi
Director Clinical Operations
View
Michele Kelly
Senior Director Clinical Quality
View
Arpit Chokshi
Associate Director - Clinical Study Team Lead
View

FAQ

iTeos Therapeutics operates in the Biotech industries. More details can be found on the official website: iteostherapeutics.com.
The headquarters of iTeos Therapeutics are located in Cambridge, United States.
The current CEO of iTeos Therapeutics is Michel Detheux
You can contact iTeos Therapeutics by phone at 3271919934.
iTeos Therapeutics currently employs 100-200 people.
iTeos Therapeutics's revenue is approximately < 1M.
Well-known competitors of iTeos Therapeutics include Dyno Therapeutics, Eikon Therapeutics, R-Zero and Aura Biosciences.
BACK TO TOP